ArticlePoultry science2026
Toxicological profile and hepatotoxic mechanism of Caulis sinomenii for safe application in chickens.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Caulis sinomenii (C. sinomenii) has been widely used to treat rheumatoid arthritis and multiple types of kidney diseases and has the potential to treat and prevent avian gout, but its safety has not been fully evaluated. In this study, the ethanol extract of C. sinomenii (CS) was obtained via an optimized method, and its composition, bioactive constituents and plasma concentration were investigated via high-performance liquid chromatography (HPLC). The toxicological profile of CS in chickens was investigated via acute and subacute toxicity experiments, including daily examination, blood tests and histopathological evaluation. The toxicity mechanism was analysed via network toxicology. Under the optimized conditions of 70.35% ethanol, a 20.26:1 ml/g liquid‒solid ratio, an extraction temperature of 81.61°C and an extraction time of 154.71 min, 203.04 mg/g of CS was obtained from C. sinomenii. Seven bioavailable components among the 13 compounds detected in the CS entered the bloodstream. The median lethal dose (LD50) of CS was 1018.83 mg/kg, with a safe dose of ≤ 127.35 mg/kg and a toxic dose of ≥ 254.71 mg/kg after oral administration. Structural and functional damages to the intestinal tract and liver were the main toxic effects, which might be attributed to 16‑epi-isositsirikine, magnograndiolide and michelenolide acting on Toll-like receptors and the MAPK, gap junction and apoptosis signalling pathways via the key targets HTR2A, NTRK1 and TLR7. In summary, C. sinomenii is hypotoxic after oral administration and has a favourable safety profile in chickens. However, excessive (≥ 254.71 mg/kg) and long-term administration should be avoided, as multiple components that act on multiple signalling pathways can cause structural and functional damage to the liver.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.